The people behind the 2025 HIV Drug Guide
The Pharmacist
Eric K. Farmer, PharmD, BCPS, AAHIVP, is an HIV clinical pharmacist at the Indiana University Health LifeCare Clinic at Methodist Hospital in Indianapolis, one of the largest providers of HIV medical services in the state of Indiana. He provides pharmacy services that include medication adherence counseling and patient education, drug information services, medication procurement, medication therapy management and medical care coordination services. He is on the Board of Directors for the American Academy of HIV Medicine and serves as clinical faculty for the Midwest AIDS Training and Education Center. Dr. Farmer graduated from Butler University with his Doctor of Pharmacy. He then completed an ASHP-accredited PGY1 pharmacy residency at Eskenazi Health in Indianapolis, and subsequently an ASHP-accredited PGY2 HIV specialty pharmacy residency at the Center for HIV/AIDS Care and Research at Boston Medical Center.
The Doctor
Jo-Ann Jose, MD, MPH, is an infectious disease physician specializing in the care and prevention of HIV, with experience working in academic and community settings. She is an assistant professor at the Feinberg School of Medicine at Northwestern University and serves as medical director of Vivent Health + TPAN. Her approach to patient care is centered on care of the whole person, shared decision-making and empowering patient involvement and engagement. She has specific research interests in implementation science, health care systems optimization and quality improvement, with specific focus on retention in care and implementation of novel therapeutics and approaches to community settings. She also serves as associate program director of the fellowship program in infectious disease at Northwestern.
The Activist
Juan Michael Porter II is an award-winning journalist, HIV advocate and educator. Currently he serves as host of HIV Unmuted, the podcast of the International AIDS Society and is senior communications manager of Global Black Gay Men Connect. From 2020 to 2025, he led coverage at TheBody and TheBodyPro, first as staff writer and then in his final two years as senior editor. In addition to POSITIVELY AWARE, he has written for PBS, POZ, the San Francisco Chronicle, the Philadelphia Inquirer, the Christian Science Monitor, the New York Observer, American Theatre and Documentary magazine, and has held fellowships with the Maynard Institute for Journalism Education, the Poynter Institute for Media Studies and the National Critics Institute.
The Associate Editor
Enid Vázquez has been Associate Editor of POSITIVELY AWARE ever since she joined the magazine in 1995. She earned her B.A. in journalism from the University of Wisconsin-Madison. She interned at The Chicago Reporter and was a cub reporter for The Hartford Courant, the oldest continuously published newspaper in the United States. Her freelance work has appeared in publications around the country. She became interested in health reporting because of the importance it has on people’s lives. It is a privilege to work on behalf of people living with HIV/AIDS, Enid says. She believes that HIV is as much a condition fueled by societal discrimination as it is by a virus. As such, it makes her reporting socio-political as well as medical. She enjoys reporting on medical updates and making them relatable to readers’ lives. Enid has a special interest in sexual violence and sexual freedom, and in serving the sex worker and transgender communities.
The Educator
Carla Blieden, PharmD, MPH, AAHIVP, reviewed the Department of Health and Human Services (HHS) guidelines for this drug guide. Dr. Blieden completed her Doctor of Pharmacy, Master of Public Health, and PGY1 Residency at the University of Southern California. She is certified as an HIV pharmacist and has worked as the clinical pharmacist at the Maternal, Child, and Adolescent/Adult Center, a family-centered HIV clinic in Los Angeles, for over a decade. She works directly with patients focusing on adherence to HIV medication, managing other chronic diseases, and analyzing HIV medication resistance.
